Literature DB >> 14707064

Alloantigen-induced CD25+CD4+ regulatory T cells can develop in vivo from CD25-CD4+ precursors in a thymus-independent process.

Mahzuz Karim1, Cherry I Kingsley, Andrew R Bushell, Birgit S Sawitzki, Kathryn J Wood.   

Abstract

The capacity of naturally occurring autoreactive CD25+CD4+ regulatory T cells (Treg) to control immune responses both in vivo and in vitro is now well established. It has been demonstrated that these cells undergo positive selection within the thymus and appear to enter the periphery as committed CD25+CD4+ Treg. We have shown previously that CD25+CD4+ Treg with the capacity to prevent skin allograft rejection can be generated by pretreatment with donor alloantigen under the cover of anti-CD4 therapy. Here we demonstrate that this process does not require an intact thymus. Furthermore, generation of these Treg is not dependent on the expansion of CD25+CD4+ thymic emigrants, because depletion of CD25+ cells before pretreatment does not prevent Treg development, and Treg can be generated from CD25-CD4+ precursors. Taken together, these results clearly demonstrate that CD25+CD4+ Treg can be generated in the periphery from CD25-CD4+ precursors in a pathway distinct to that by which naturally occurring autoreactive CD25+CD4+ Treg develop. These observations may have important implications for the design of protocols, both experimental and clinical, for the induction of tolerance to autoantigens or alloantigens in adults with limited thymic function.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14707064     DOI: 10.4049/jimmunol.172.2.923

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  52 in total

Review 1.  Tregs and transplantation tolerance.

Authors:  Patrick T Walsh; Devon K Taylor; Laurence A Turka
Journal:  J Clin Invest       Date:  2004-11       Impact factor: 14.808

2.  Antigen-specific induced Foxp3+ regulatory T cells are generated following CD40/CD154 blockade.

Authors:  Ivana R Ferrer; Maylene E Wagener; Minqing Song; Allan D Kirk; Christian P Larsen; Mandy L Ford
Journal:  Proc Natl Acad Sci U S A       Date:  2011-12-05       Impact factor: 11.205

3.  Antigen-non-specific regulation centered on CD25+Foxp3+ Treg cells.

Authors:  Gangzheng Hu; Zhongmin Liu; Changqing Zheng; Song Guo Zheng
Journal:  Cell Mol Immunol       Date:  2010-08-23       Impact factor: 11.530

Review 4.  CD4+ regulatory cells as a potential immunotherapy.

Authors:  Zoltán Fehérvari; Shimon Sakaguchi
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2005-09-29       Impact factor: 6.237

5.  FoxP3(+)CD4(+)CD25(+) T cells with regulatory properties can be cultured from colonic mucosa of patients with Crohn's disease.

Authors:  J Kelsen; J Agnholt; H J Hoffmann; J L Rømer; C L Hvas; J F Dahlerup
Journal:  Clin Exp Immunol       Date:  2005-09       Impact factor: 4.330

Review 6.  Regulatory T cells in pregnancy.

Authors:  Ana Claudia Zenclussen
Journal:  Springer Semin Immunopathol       Date:  2006-07-13

7.  Influence of direct and indirect allorecognition pathways on CD4+CD25+ regulatory T-cell function in transplantation.

Authors:  Alberto Sánchez-Fueyo; Christoph M Domenig; Christophe Mariat; Sophoclis Alexopoulos; Xin X Zheng; Terry B Strom
Journal:  Transpl Int       Date:  2007-03-16       Impact factor: 3.782

Review 8.  Cell mediators of autoimmune hepatitis and their therapeutic implications.

Authors:  Aldo J Montano-Loza; Albert J Czaja
Journal:  Dig Dis Sci       Date:  2014-12-09       Impact factor: 3.199

9.  Functional Foxp3+ CD4+ CD25(Bright+) "natural" regulatory T cells are abundant in rabbit conjunctiva and suppress virus-specific CD4+ and CD8+ effector T cells during ocular herpes infection.

Authors:  Anthony B Nesburn; Ilham Bettahi; Gargi Dasgupta; Alami Aziz Chentoufi; Xiuli Zhang; Sylvaine You; Naoyuki Morishige; Andrew J Wahlert; Donald J Brown; James V Jester; Steven L Wechsler; Lbachir BenMohamed
Journal:  J Virol       Date:  2007-05-02       Impact factor: 5.103

Review 10.  Exploring the Pathogenic Role and Therapeutic Implications of Interleukin 2 in Autoimmune Hepatitis.

Authors:  Albert J Czaja
Journal:  Dig Dis Sci       Date:  2020-08-24       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.